Tezepelumab in severe chronic rhinosinusitis with nasal polyps
This Medudy course is a video tutorial for physicians on the topic of "Tezepelumab in severe chronic rhinosinusitis with nasal polyps". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. In the treatment of chronic rhinosinusitis with nasal polyps, biologic therapies that target the [...]
Berberine ursodeoxycholic acid for type 2 diabetes
This Medudy course is a video tutorial for physicians on the topic of "Berberine ursodeoxycholic acid in type 2 diabetes". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Berberine ursodeoxycholate or HTD1801 is a novel oral metabolic modulator with a dual mechanism of action. By activating the adenosine monophosphate kinase [...]
Oral IL-23 receptor antagonist for plaque psoriasis
This Medudy course is a video tutorial for physicians on the topic "Oral IL-23 receptor antagonist in plaque psoriasis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Several biologics are effective and safer in psoriasis therapy than older oral therapies, but require injections, [...]
Annual Meeting of ASCO 2025 Gynecologic Oncology
This Medudy course is a congress report for physicians on the topic "Annual Meeting of ASCO 2025: Gynecologic Oncology" with the AI avatar of Prof. Dr. Fabian Trillsch. The most important studies of the congress will be summarized and the expert's assessment of the clinical relevance will be given. Each study is presented in short segments. The [...]
Oral anticoagulants for atrial fibrillation and severe chronic kidney disease
This Medudy course is a video tutorial for physicians on the topic of "Oral Anticoagulants in Atrial Fibrillation and Severe Chronic Kidney Disease", in which we summarize the latest and most important clinical studies for you. Chronic kidney disease (CKD) increases the risk of cardiovascular complications, including atrial fibrillation (AF). Both conditions are associated with [...]
Etiology and diagnosis of hypermenorrhea
This Medudy course is a video tutorial for doctors on the topic of "Etiology and diagnosis of hypermenorrhea". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Hypermenorrhea is defined as excessive menstrual blood loss that significantly impairs quality of life. Despite the clinical [...]
Palliative telecare and HRQoL for COPD, HI or ILD
This Medudy course is a video tutorial for physicians on the topic of "Palliative Telecare and HRQoL in COPD, HI or ILD". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Many patients with chronic obstructive pulmonary disease, heart failure and interstitial lung disease [...].
Acute pain therapy through NaV1.8 inhibition
This Medudy course is a video tutorial for physicians on the topic of "Acute pain therapy using NaV1.8 inhibition". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Acute pain is a major clinical challenge and is often treated with opioids, although [...]
Semaglutide for chronic kidney disease and type 2 diabetes
This Medudy course is a video tutorial for physicians on the topic of "Semaglutide in chronic kidney disease and type 2 diabetes". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. More than half a billion people worldwide suffer from chronic kidney disease (CKD). In many [...]
Resmetirome in NASH with liver fibrosis
This Medudy course is a video tutorial for physicians on the topic of "Resmetirome in NASH with liver fibrosis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Resmetirome is an oral, liver-targeted, beta-selective thyroid hormone receptor agonist. It is in the [...]